Aviscumine Uses, Dosage, Side Effects and more

Cy 503 is under investigation in clinical trial NCT00658437 (Aviscumine for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy).

Attribute	Details
Trade Name	Aviscumine
Generic	Aviscumine
Aviscumine Other Names	Aviscumine
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph